Drug compliance and the Morisky Adherence Scale: An expression of concern and a warning.
Alain Li-Wan-PoGregory Mark PetersonPublished in: Journal of clinical pharmacy and therapeutics (2020)
The study of optimal prescribing is an important endeavour and adherence studies are but one aspect. We report that using and citing the Morisky Adherence scale in any detail is a risky business. Prior approval is required unless one is prepared to pay up, retrospectively. We require all authors to certify they have no conflicts of interest with respect to the scale.